Literature DB >> 901769

Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor).

W Kisiel, K Fujikawa, E W Davie.   

Abstract

Bovine factor VII (proconvertin) is a plasma glycoprotein that participates in the extrinsic pathway of blood coagulation. It has a molecular weight of 45 500 and is composed of a single polypeptide chain with an amino-terminal alanine residue. Factor VII is readily converted to factor VIIa by factor XIIa (activated Hageman factor) employing an enzyme to substrate weight ratio of 1:50. Factor VIIa is composed of a light and a heavy chain held together by a disulfide bond(s). The heavy chain, which is formed from the carboxyl-terminal region of the precursor, contains an amino-terminal sequence of Ile-Val-Gly-Gly-. The heavy chain also contains the active-site sequence of -Phe-Cys-Ala-Gly-Tyr-Thr-Asp-Gly-Thr-Lys-Asp-Ala-Cys-Lys-Gly-Asp-Ser-Gly-Gly-Pro-His-. This sequence is homologous with the active-site region of a number of plasma serine proteases. These data indicate that factor VII is a typical precursor of a serine protease which is converted to an enzyme by factor XIIa by the cleavage of a single, internal peptide bond.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 901769     DOI: 10.1021/bi00638a009

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  An endothelial cell-dependent pathway of coagulation.

Authors:  D Stern; P Nawroth; D Handley; W Kisiel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

2.  Activation of factor IX bound to cultured bovine aortic endothelial cells.

Authors:  D M Stern; M Drillings; W Kisiel; P Nawroth; H L Nossel; K S LaGamma
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

3.  Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7).

Authors:  G Marchetti; P Patracchini; D Gemmati; V DeRosa; M Pinotti; G Rodorigo; A Casonato; A Girolami; F Bernardi
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

4.  Expression and purification of recombinant human coagulation factor VII fused to a histidine tag using Gateway technology.

Authors:  Raheleh Halabian; Mahdi Edalati Fathabad; Nasser Masroori; Amaneh Mohammadi Roushandeh; Sasan Saki; Nasser Amirizadeh; Ali Jahanian Najafabadi; Ahmad Gharehbaghian; Mehryar Habibi Roudkenar
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

5.  Activation of human factor IX (Christmas factor).

Authors:  R G Di Scipio; K Kurachi; E W Davie
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

Review 6.  Tissue factor: a key molecule in hemostatic and nonhemostatic systems.

Authors:  James H Morrissey
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

7.  Binding of human factor VII and VIIa to monocytes.

Authors:  G J Broze
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

8.  Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.

Authors:  R C Wiggins; D J Loskutoff; C G Cochrane; J H Griffin; T S Edgington
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

9.  Turnover of factor X and of prothrombin in rabbits fed on a standard or cholesterol-supplemented diet.

Authors:  K A Mitropoulos; M P Esnouf
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

10.  Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis.

Authors:  Yves Decrem; Géraldine Rath; Virginie Blasioli; Philippe Cauchie; Séverine Robert; Jérôme Beaufays; Jean-Marie Frère; Olivier Feron; Jean-Michel Dogné; Chantal Dessy; Luc Vanhamme; Edmond Godfroid
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.